Health News

Latest articles in Health

Keto diet cut liver fat by 67 percent in weight-matched trial

A randomised trial published in Cell Metabolism found that a ketogenic diet reduced liver fat by 67 percent in adults with obesity, prediabetes and fatty liver disease, compared with 45 percent on a Mediterranean diet and 45 percent on a very-low-fat plant-forward diet. Weight loss was similar across the three groups, at about 10 percent, which suggests carbohydrate restriction had effects beyond weight. Half of the keto group no longer met the criteria for prediabetes, against 29 percent on Mediterranean and 7 percent on low-fat. The trial was small, with 55 participants randomised and 42 completing testing.

Ohio University E. coli cases reach 17 with no source named

The Athens City-County Health Department now counts 17 laboratory-confirmed Shiga toxin-producing E. coli cases among Ohio University students, plus four suspected cases, up from four on 11 November. All confirmed patients fell ill between 5 and 10 November. One person was hospitalised and released, and no case of hemolytic uremic syndrome has been reported. No food, dining hall, event or water source has been identified, and Thanksgiving break begins in a week.

Congo's Ebola outbreak passes 10,600 cases as contact tracing falls short

The Bundibugyo virus outbreak in the Democratic Republic of the Congo has reached 10,668 confirmed cases and 5,198 deaths, a case fatality rate of 48.7%, according to WHO figures to November 3. Another 964 confirmed cases and 511 deaths were reported in the latest reporting period. Cases have appeared in 67 health zones across eight provinces, with Ituri and North Kivu carrying most of the burden. Only 86% of contacts were seen daily against a 95% target. Britain evacuated one confirmed case, a health worker, to London on November 5. Kenya has reported nine cases and two deaths. The response is running against a 95% contact-tracing target it has not met, and transmission is continuing in more than fifty health zones. Two candidate vaccines and a treatment trial are under way, but neither has yet changed the shape of the epidemic.

US loses measles elimination status after 26 years

The Pan American Health Organization has announced that the United States has lost its measles elimination status, 26 years after the country was declared free of sustained local transmission. More than 5,400 measles cases have been reported in 2026, the highest yearly count since 1991, and more than 7,500 since January 2025. Eight deaths have been reported this year. About 96% of 2026 cases were in people who were unvaccinated or of unknown status. Two doses of the MMR vaccine are about 97% effective. Canada, the UK and Spain have already lost the same status. The elimination designation had stood since 2000.

Governments bring 230 new pledges to Manila summit on child violence

More than 230 new pledges will be announced at the Second Global Ministerial Conference on Ending Violence Against Children, which opens in Manila on 18 November. Tanzania plans a US$190 million child protection investment, Nepal promises to halve school violence by 2030, and Chile commits to protecting 3.4 million children from school violence and cyberbullying. Thirty countries are pledging for the first time, taking the total since Bogotá in 2024 past 630 pledges from 140 countries. WHO says violence affects more than a billion children a year and is linked to lasting health harm.

US measles cases pass 5,000 as the death toll reaches double digits

The United States has recorded 5,412 confirmed measles cases in 2026, the first time above 5,000 since 1991, and state health departments count 10 measles-related deaths. The CDC lists six, double the 2025 figure, after switching from state tallies to national mortality data. Pennsylvania has confirmed six deaths, Wisconsin reported an infant's death and New York recorded its first in more than 30 years. Of this year's patients, 20 percent are children five and under and 93 percent were unvaccinated or of unknown status. The Pan American Health Organization was expected to decide whether the country keeps its measles-free certification.

Shingles shot tied to less heart disease in a seven-year comparison

Adults who received the recombinant shingles vaccine Shingrix had a 9% lower burden of cardiovascular disease over seven years than those who got the older live vaccine, according to a study in Nature Medicine. Heart failure and ischaemic heart disease drove the difference, and the authors say the finding is a signal that needs testing in a randomised trial.

FDA clears asundexian to cut repeat stroke risk

The FDA approved asundexian, sold as Sunharbo, on November 9 to reduce the risk of stroke in adults who have had a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The drug targets factor XIa, a clotting protein, and is part of a class built to prevent clots with less bleeding than older blood thinners. The approval is one of 48 new drugs cleared by the agency in 2026, a list that also includes bepirovirsen for chronic hepatitis B, approved in October.

US nears loss of measles elimination status as 2026 cases pass 5,100

The United States is close to losing the measles elimination status it has held since 2000, with 5,182 confirmed cases reported as of November 5 and six deaths this year. The CDC has logged 38 outbreaks, and nearly all cases were acquired inside the country rather than imported. About 20 percent of patients are children aged five and under, and 93 percent are unvaccinated or have unknown vaccine status. The Pan American Health Organization is reviewing whether a year of continuous transmission has ended elimination. This is the worst US measles year since 1991, and coverage with two doses has slipped below 90 percent in several states, well under the roughly 95 percent needed to stop transmission.

Cancer society now recommends routine PSA screening for most men

The American Cancer Society issued a new prostate cancer screening guideline on Thursday that, for the first time, directly recommends routine PSA blood testing rather than leaving it to a discussion between doctor and patient. Average-risk men aged 50 to 69 should be tested every two years. Black men and men with a strong family history should start at 45 and test every year. The change rests on a systematic evidence review that found screening lowers deaths and advanced-stage diagnoses. The society estimates 333,830 new prostate cancer cases and 36,320 deaths in the United States this year.